Recent

% | $
Quotes you view appear here for quick access.

RXi Pharmaceuticals Corporation Message Board

  • red900901 red900901 Apr 29, 2013 8:51 AM Flag

    RXi Pharmaceuticals Announces Investor and Analyst Symposium - Friday July 12, from 11:00am to 2:00pm

     

    April 29, 2013

    RXi Pharmaceuticals Announces Investor and Analyst Symposium

    Westborough, MA –(BUSINESS WIRE) – RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today  announced that it will hold its first Investor and Analyst Symposium.

    During this meeting, the company Management and members of its Scientific Advisory Board will provide more details on RXi’s current clinical development compound for the treatment of dermal scarring, RXI-109, as well as insights into the company’s other research programs and their potential. “As mentioned on several occasions, RXi Pharmaceuticals will have the complete unblinded data of their two Phase 1 studies available around the middle of this year”, said Dr. Geert Cauwenbergh, President and CEO of the Company. He added that, “At this Investor and Analyst Symposium, we expect to announce the formal transition of RXI-109 into a Phase 2 clinical development program, and also provide more detail on the indications and patient population we will target in our Phase 2 studies. In addition the company will also give an update on its other earlier stage programs, with special emphasis on the ophthalmologic applications of its game changing self delivering RNAi platform.”

    This event will be held on Friday July 12, from 11:00am to 2:00pm at the OTCQX Market Center, 304 Hudson Street, New York, NY.  Registration is required to attend this event, please contact Tamara McGrillen at 508-929-3646. A live webcast of the presentation will be available on the “Investors” section of the Company’s website. A replay of the presentation will be available for 90 days.

    This topic is deleted.
 
RXII
0.3856-0.0044(-1.13%)3:07 PMEDT